Meeder Asset Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Meeder Asset Management’s Portfolio ODT Stock Details ODT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,640	Closed	-$70K	–	2465
2020 Q2	$70K	Hold	1,640	–	–	﹤0.01%	858
2020 Q1	$46K	Sell	1,640 -25	-2%	-$729	﹤0.01%	945
2019 Q4	$54K	Sell	1,665 -47	-3%	-$1.46K	﹤0.01%	1000
2019 Q3	$44K	Buy	1,712 +138	+9%	+$4.62K	﹤0.01%	1057
2019 Q2	$57K	Buy	1,574 +1,047	+199%	+$25.1K	﹤0.01%	915
2019 Q1	$12K	Buy	527 +443	+527%	+$7.75K	﹤0.01%	1208
2018 Q4	$1K	Buy	+84	New	+$1.31K	﹤0.01%	1677

Other funds holding ODT

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Meeder Asset Management's ODT Position: Q3 2020 in Review

Meeder Asset Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2020, closing a stake of 1,640 shares — an estimated $70K sold.

Meeder Asset Management first reported a position in ODT in Q4 2018 and held it in 7 quarters. The position peaked at $70K in Q2 2020. 89 funds tracked by Wall St. Rank hold ODT as of Q3 2020.

Meeder Asset Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Meeder Asset Management sold 1,640 Odonate Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $70K.
Meeder Asset Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2018 and held it in 7 quarters.
Meeder Asset Management's Odonate Therapeutics, Inc. Common Stock position peaked at $70K in Q2 2020.
89 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.